Duration of Social Isolation Affects Production of Nitric Oxide in the Rat Brain.
neurodevelopment
nitric oxide
nitric oxide synthase
oxidative stress
social isolation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Sep 2021
25 Sep 2021
Historique:
received:
30
08
2021
revised:
17
09
2021
accepted:
22
09
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Social isolation deprives rodents of social interactions that are critical for normal development of brain and behavior. Several studies have indicated that postweaning isolation rearing may affect nitric oxide (NO) production. The aim of this study was to compare selected behavioral and biochemical changes related to NO production in the brain of rats reared in social isolation for different duration. At the age of 21 days, male Sprague Dawley rats were randomly assigned into four groups reared in isolation or socially for 10 or 29 weeks. At the end of the rearing, open-field and prepulse inhibition (PPI) tests were carried out. Furthermore, in several brain areas we assessed NO synthase (NOS) activity, protein expression of nNOS and iNOS isoforms and the concentration of conjugated dienes (CD), a marker of oxidative damage and lipid peroxidation. Social isolation for 10 weeks resulted in a significant decrease in PPI, which was accompanied by a decrease in NOS activity in the cerebral cortex and the cerebellum, an increase in iNOS in the hippocampus and an increase in CD concentration in cortex homogenate. On the other hand, a 29 week isolation had an opposite effect on NOS activity, which increased in the cerebral cortex and the cerebellum in animals reared in social isolation, accompanied by a decrease in CD concentration. The decrease in NOS activity after 10 weeks of isolation might have been caused by chronic stress induced by social isolation, which has been documented in previous studies. The increased oxidative state might result in the depleted NO bioavailability, as NO reacts with superoxide radical creating peroxynitrite. After 29 weeks of isolation, this loss of NO might be compensated by the subsequent increase in NOS activity.
Identifiants
pubmed: 34638682
pii: ijms221910340
doi: 10.3390/ijms221910340
pmc: PMC8509065
pii:
doi:
Substances chimiques
Peroxynitrous Acid
14691-52-2
Nitric Oxide
31C4KY9ESH
Nitric Oxide Synthase
EC 1.14.13.39
Nitric Oxide Synthase Type I
EC 1.14.13.39
Nitric Oxide Synthase Type II
EC 1.14.13.39
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
ID : 2/0118/21
Références
Neuroscience. 2009 Mar 3;159(1):21-30
pubmed: 19141315
Int J Mol Sci. 2021 Jun 20;22(12):
pubmed: 34203049
Brain Behav Immun. 2016 Jan;51:119-130
pubmed: 26254231
Curr Protoc Neurosci. 2001 May;Chapter 8:Unit 8.7
pubmed: 18428548
J Neurosci Res. 2011 Sep;89(9):1461-70
pubmed: 21656845
Metab Brain Dis. 2013 Dec;28(4):687-96
pubmed: 24000072
J Neurochem. 2007 Nov;103(3):1145-56
pubmed: 17666041
Front Physiol. 2015 May 11;6:139
pubmed: 26029110
J Mol Cell Cardiol. 1997 Dec;29(12):3365-74
pubmed: 9441842
Psychopharmacology (Berl). 2001 Jul;156(2-3):234-58
pubmed: 11549226
Pharmacol Biochem Behav. 1993 Mar;44(3):741-4
pubmed: 8451276
J Neurochem. 2007 Dec;103(5):1843-54
pubmed: 17854383
Curr Opin Neurobiol. 1997 Jun;7(3):374-8
pubmed: 9232800
J Neural Transm (Vienna). 2014 Jan;121(1):3-14
pubmed: 23851625
Neuroscientist. 2010 Aug;16(4):435-52
pubmed: 20817920
Neurochem Int. 2013 Sep;63(3):172-9
pubmed: 23770205
Cerebellum. 2012 Mar;11(1):50-61
pubmed: 21104176
Horm Behav. 2011 Jun;60(1):28-36
pubmed: 21316368
Front Synaptic Neurosci. 2014 Mar 18;6:4
pubmed: 24672476
J Biol Chem. 2000 Sep 8;275(36):28139-43
pubmed: 10874031
Cell. 1993 Dec 31;75(7):1273-86
pubmed: 7505721
Neuropsychobiology. 2005;52(3):111-7
pubmed: 16110244
Mol Psychiatry. 2001 Jan;6(1):66-73
pubmed: 11244487
Alcohol Clin Exp Res. 2004 Nov;28(11):1746-51
pubmed: 15547462
Brain Res. 2011 Apr 18;1385:175-81
pubmed: 21338587
Neuropsychopharmacology. 2008 Jul;33(8):1874-83
pubmed: 17895915
Schizophr Res. 2005 Oct 1;78(1):69-86
pubmed: 16005189
Science. 1990 Aug 3;249(4968):556-60
pubmed: 2166337
Proteomics. 2003 Apr;3(4):513-26
pubmed: 12687618
Antioxid Redox Signal. 2012 Dec 1;17(11):1590-609
pubmed: 22114878
Front Behav Neurosci. 2017 May 31;11:101
pubmed: 28620285
Schizophr Res. 2006 Jan 31;81(2-3):291-300
pubmed: 16309894
J Pharmacol Exp Ther. 2005 Feb;312(2):733-41
pubmed: 15494551
Int J Mol Sci. 2019 Aug 02;20(15):
pubmed: 31382355
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3113-8
pubmed: 23359715
Front Cell Neurosci. 2019 Jul 23;13:331
pubmed: 31396053
Behav Brain Res. 2011 Mar 1;217(2):416-23
pubmed: 21074571
Brain Res. 2001 Aug 3;909(1-2):20-45
pubmed: 11478918
Physiol Behav. 2015 Jun 1;145:38-44
pubmed: 25817356
Int J Mol Sci. 2021 Jun 04;22(11):
pubmed: 34199936
Braz J Med Biol Res. 2008 Dec;41(12):1037-46
pubmed: 19148364
Horm Behav. 2008 Jun;54(1):90-7
pubmed: 18377905
Neurosci Biobehav Rev. 2010 May;34(6):808-20
pubmed: 20171244
Front Cell Neurosci. 2013 Oct 31;7:190
pubmed: 24198758
Cell Stress Chaperones. 2011 Mar;16(2):143-52
pubmed: 20890773
Cell Tissue Res. 2019 Jul;377(1):45-58
pubmed: 30649612
Mol Aspects Med. 2004 Feb-Apr;25(1-2):75-89
pubmed: 15051318
Physiol Behav. 1999 Sep;67(3):385-92
pubmed: 10497957
CNS Neurol Disord Drug Targets. 2006 Oct;5(5):561-8
pubmed: 17073658
J Neurochem. 2006 Jun;97(6):1676-89
pubmed: 16805776
Behav Brain Res. 2006 Dec 15;175(2):408-14
pubmed: 17069898
Neuroscience. 2012 Oct 25;223:238-45
pubmed: 22885231
Behav Brain Res. 2015 Apr 1;282:201-8
pubmed: 25591473
Proc Natl Acad Sci U S A. 1990 Jan;87(2):682-5
pubmed: 1689048
Eur J Pharmacol. 2004 Oct 25;503(1-3):103-7
pubmed: 15496304
J Cell Biol. 2008 Dec 15;183(6):1115-27
pubmed: 19075115
Psychopharmacology (Berl). 2010 Jan;207(4):571-81
pubmed: 19816675
Mol Brain. 2009 Jun 18;2:19
pubmed: 19538708
Neurosci Lett. 2014 Nov 7;583:165-9
pubmed: 25016153
Neurochem Int. 2019 Oct;129:104473
pubmed: 31128132
Mol Neurobiol. 2017 Dec;54(10):8071-8089
pubmed: 27889895
Endocrinology. 2008 Jun;149(6):2727-36
pubmed: 18308845
Psychopharmacology (Berl). 2014 Feb;231(4):663-72
pubmed: 24101156
Handb Exp Pharmacol. 2006;(172):171-98
pubmed: 16610360
Handb Exp Pharmacol. 2009;(191):549-79
pubmed: 19089345
Biomed Pharmacother. 2018 Sep;105:1205-1222
pubmed: 30021357